CR Medical (01515) Releases Updated Board and Committee Composition

Bulletin Express03-11

China Resources Medical Holdings Company Limited (CR Medical, 01515) disclosed its latest board structure and committee memberships on 11 March 2026.

Board Composition • Total directors: 9 – Executive Directors: 4 (Yu Hai – Chairman; Zhang Chuang – Chief Executive Officer; Wang Yuexing; Wu Xinchun – Vice President) – Non-Executive Director: 1 (Fang Xin) – Independent Non-Executive Directors (INEDs): 4 (Wu Ting Yuk, Anthony; Fu Tingmei; Zhou Peng; Lo Wing Sze)

Committee Structure 1. Audit Committee • Chair: Fu Tingmei (INED) • Members: Wu Ting Yuk, Anthony (INED); Zhou Peng (INED); Fang Xin (NED)

2. Nomination Committee • Chair: Wu Ting Yuk, Anthony (INED) • Members: Yu Hai (Executive Director); Lo Wing Sze (INED)

3. Remuneration Committee • Chair: Yu Hai (Executive Director) • Members: Fu Tingmei (INED); Lo Wing Sze (INED)

Key Takeaways • Independent directors hold 4 of 9 board seats, underscoring compliance with Hong Kong governance requirements for board independence. • All three statutory committees are led by independent directors or the board chairman, aligning with best-practice standards for oversight and accountability.

The announcement did not indicate any changes to the existing board or committee memberships beyond the above disclosure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1161577491?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-11 18:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161577491","market":"us","top_or_hot":-1,"title":"CR Medical (01515) Releases Updated Board and Committee Composition","media":"Bulletin Express","content":"<p>China Resources Medical Holdings Company Limited (CR Medical, 01515) disclosed its latest board structure and committee memberships on 11 March 2026.</p>\n<p>Board Composition  \n• Total directors: 9  \n  – Executive Directors: 4 (Yu Hai – Chairman; Zhang Chuang – Chief Executive Officer; Wang Yuexing; Wu Xinchun – Vice President)  \n  – Non-Executive Director: 1 (Fang Xin)  \n  – Independent Non-Executive Directors (INEDs): 4 (Wu Ting Yuk, Anthony; Fu Tingmei; Zhou Peng; Lo Wing Sze)</p>\n<p>Committee Structure  \n1. Audit Committee  \n   • Chair: Fu Tingmei (INED)  \n   • Members: Wu Ting Yuk, Anthony (INED); Zhou Peng (INED); Fang Xin (NED)</p>\n<p>2. Nomination Committee  \n   • Chair: Wu Ting Yuk, Anthony (INED)  \n   • Members: Yu Hai (Executive Director); Lo Wing Sze (INED)</p>\n<p>3. Remuneration Committee  \n   • Chair: Yu Hai (Executive Director)  \n   • Members: Fu Tingmei (INED); Lo Wing Sze (INED)</p>\n<p>Key Takeaways  \n• Independent directors hold 4 of 9 board seats, underscoring compliance with Hong Kong governance requirements for board independence.  \n• All three statutory committees are led by independent directors or the board chairman, aligning with best-practice standards for oversight and accountability.</p>\n<p>The announcement did not indicate any changes to the existing board or committee memberships beyond the above disclosure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CR Medical (01515) Releases Updated Board and Committee Composition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCR Medical (01515) Releases Updated Board and Committee Composition\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-11 18:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Resources Medical Holdings Company Limited (CR Medical, 01515) disclosed its latest board structure and committee memberships on 11 March 2026.</p>\n<p>Board Composition  \n• Total directors: 9  \n  – Executive Directors: 4 (Yu Hai – Chairman; Zhang Chuang – Chief Executive Officer; Wang Yuexing; Wu Xinchun – Vice President)  \n  – Non-Executive Director: 1 (Fang Xin)  \n  – Independent Non-Executive Directors (INEDs): 4 (Wu Ting Yuk, Anthony; Fu Tingmei; Zhou Peng; Lo Wing Sze)</p>\n<p>Committee Structure  \n1. Audit Committee  \n   • Chair: Fu Tingmei (INED)  \n   • Members: Wu Ting Yuk, Anthony (INED); Zhou Peng (INED); Fang Xin (NED)</p>\n<p>2. Nomination Committee  \n   • Chair: Wu Ting Yuk, Anthony (INED)  \n   • Members: Yu Hai (Executive Director); Lo Wing Sze (INED)</p>\n<p>3. Remuneration Committee  \n   • Chair: Yu Hai (Executive Director)  \n   • Members: Fu Tingmei (INED); Lo Wing Sze (INED)</p>\n<p>Key Takeaways  \n• Independent directors hold 4 of 9 board seats, underscoring compliance with Hong Kong governance requirements for board independence.  \n• All three statutory committees are led by independent directors or the board chairman, aligning with best-practice standards for oversight and accountability.</p>\n<p>The announcement did not indicate any changes to the existing board or committee memberships beyond the above disclosure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01515","symbol_name":"华润医疗","start_time":0,"source_url":"","article_id":"1161577491","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161577491","pubTimestamp":1773224633,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Resources Medical Holdings Company Limited (CR Medical, 01515) disclosed its latest board structure and committee memberships on 11 March 2026. Board Composition   • Total directors: 9     –...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01515":"华润医疗"},"translate_title":"华润医疗(01515)发布更新董事会及委员会组成","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01515":1},"content_text":"China Resources Medical Holdings Company Limited (CR Medical, 01515) disclosed its latest board structure and committee memberships on 11 March 2026.\nBoard Composition  \n• Total directors: 9  \n  – Executive Directors: 4 (Yu Hai – Chairman; Zhang Chuang – Chief Executive Officer; Wang Yuexing; Wu Xinchun – Vice President)  \n  – Non-Executive Director: 1 (Fang Xin)  \n  – Independent Non-Executive Directors (INEDs): 4 (Wu Ting Yuk, Anthony; Fu Tingmei; Zhou Peng; Lo Wing Sze)\nCommittee Structure  \n1. Audit Committee  \n   • Chair: Fu Tingmei (INED)  \n   • Members: Wu Ting Yuk, Anthony (INED); Zhou Peng (INED); Fang Xin (NED)\n2. Nomination Committee  \n   • Chair: Wu Ting Yuk, Anthony (INED)  \n   • Members: Yu Hai (Executive Director); Lo Wing Sze (INED)\n3. Remuneration Committee  \n   • Chair: Yu Hai (Executive Director)  \n   • Members: Fu Tingmei (INED); Lo Wing Sze (INED)\nKey Takeaways  \n• Independent directors hold 4 of 9 board seats, underscoring compliance with Hong Kong governance requirements for board independence.  \n• All three statutory committees are led by independent directors or the board chairman, aligning with best-practice standards for oversight and accountability.\nThe announcement did not indicate any changes to the existing board or committee memberships beyond the above disclosure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1161577491","isCrawlerRequest":true}